Aline S C Fabricio
Overview
Explore the profile of Aline S C Fabricio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
502
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ravaggi A, Bergamaschi C, Galbiati C, Zanotti L, Fabricio A, Gion M, et al.
Biomedicines
. 2024 Oct;
12(10).
PMID: 39457705
Background/objectives: Endometriosis (END) is a painful gynecological condition. Clinical examination, imaging, and laparoscopy can provide a definitive diagnosis of END. Nonetheless, non-invasive biomarkers could help enhance and streamline the diagnostic...
2.
Pasello G, Fabricio A, Del Bianco P, Salizzato V, Favaretto A, Piccin L, et al.
J Transl Med
. 2024 Mar;
22(1):242.
PMID: 38443899
Background: Immune Checkpoint Inhibitors (ICIs) lead to durable response and a significant increase in long-term survival in patients with advanced malignant melanoma (MM) and Non-Small Cell Lung Cancer (NSCLC). The...
3.
Cappelletto E, Fasiolo L, Salizzato V, Piccin L, Fabozzi A, Contato A, et al.
Int J Biol Markers
. 2024 Feb;
39(1):9-22.
PMID: 38407953
Aim: To evaluate cytokine and soluble programmed death ligand-1 (sPD-L1) levels in the serum and plasma of cancer patients treated with immunotherapy, and to test different assays. Methods: Three Luminex...
4.
Gion M, De Gobbi R, Zorzi M, Carretta G, Leonardi L, Guzzinati S, et al.
Int J Biol Markers
. 2023 Mar;
38(1):61-71.
PMID: 36855811
Purpose: The overuse of laboratory tests contributes to impair health systems effectiveness, tumor markers (TMs) being a paradigmatic example. In the present study we applied indicators of TMs appropriateness developed...
5.
Gion M, Cardinali G, Guzzinati S, Morandi P, Trevisiol C, Fabricio A, et al.
Risk Manag Healthc Policy
. 2022 May;
15:1087-1100.
PMID: 35615584
Purpose: Clinical practice guidelines (CPGs) recommend against intensive follow-up in asymptomatic women with breast cancer (BC). The present study assessed the adherence to CPGs of diagnostic tests ordering during BC...
6.
Dittadi R, Fabricio A, Gion M
Clin Chem Lab Med
. 2022 Mar;
60(6):e136-e137.
PMID: 35263822
No abstract available.
7.
Gallo E, Barbiellini Amidei C, Barbieri G, Fabricio A, Gion M, Pitter G, et al.
Environ Res
. 2021 Aug;
203:111794.
PMID: 34358507
Background: Per- and poly-fluoroalkyl substances (PFAS) are persistent and widespread environmental pollutants. People living in Veneto Region (Italy) have been exposed from the late 1970s to 2013 to elevated concentrations...
8.
Zare Jeddi M, Soltanmohammadi R, Barbieri G, Fabricio A, Pitter G, Dalla Zuanna T, et al.
Rev Environ Health
. 2021 May;
37(2):211-228.
PMID: 34036763
Exposure to per- and polyfluoroalkyl substances (PFAS), ubiquitous persistent environmental contaminants, has led to substantial global concern due to their potential environmental and human health effects. Several epidemiological studies have...
9.
Ferro S, Bottigliengo D, Gregori D, Fabricio A, Gion M, Baldi I
J Pers Med
. 2021 Apr;
11(4).
PMID: 33916398
Primary breast cancer (PBC) is a heterogeneous disease at the clinical, histopathological, and molecular levels. The improved classification of PBC might be important to identify subgroups of the disease, relevant...
10.
Zare Jeddi M, Dalla Zuanna T, Barbieri G, Fabricio A, Dapra F, Fletcher T, et al.
Int J Environ Res Public Health
. 2021 Feb;
18(3).
PMID: 33572770
Background: Studies on the association between perfluoroalkyl substances (PFAS) and metabolic syndrome (MetS) are limited, and results are inconsistent. We aimed to examine the associations between PFAS serum levels and...